Treatment of Clinically Isolated Syndrome (CIS) suggestive of MS with a DMD may delay the conversion to RRMS [1], and DMD treatment of RRMS may substantially decrease the risk of conversion to secondary progressive MS [2, 3]. The gene discussed is DMD; the disease is in situ carcinoma.